retatrutide drops (RETA) – Research Peptide Retatrutide Blood Sugar Results: 2.02%

Medical care may include evaluation for prescription anti-obesity medicines or diabetes treatment when appropriate

You want to lose fat, not muscle

Instead, GIP may counteract nausea and vomiting via direct modulation of the area postrema/NST emesis circuitry (169) and exert protective effects on unfavorable altered gut motility (44)

At the end of the day, GLP-1 patches are not FDA-approved GLP-1 medications

I was putting in the work

Reported incidences included nausea (5.922.2%), diarrhea (8.825.3%), vomiting (2.99.1%), and constipation (8.816.2%), with discontinuation rates reaching 19% in high-dose monthly regimens (816 mg) [62,63,64]